Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Drreddys Laboratories

Drreddys Laboratories reported INR50.59B in Operating Expenses for its fiscal quarter ending in March of 2023.

Operating Expenses Change
ANI Pharmaceuticals ANIP:US USD 96.89M 4.48M
Bayer BAYN:GR EUR 11.42B 848M
Catalent CTLT:US USD 1.01B 49M
Cipla CIPLA:IN INR 50.94B 4.2B
Corcept Therapeutics CORT:US USD 90.8M 10.24M
Drreddys Laboratories RDY:US INR 50.59B 687M
Endo International ENDP:US USD 511.81M 280.86M
GlaxoSmithKline GSK:LN GBP 4.87B 640M
Hikma Pharmaceutical HIK:LN USD 1.24B 280M
Horizon Pharma HZNP:US USD 796.06M 27.97M
Lonza Group LONN:SW CHF 2.35B 8M
Novartis NOVN:VX USD 10.35B 700M
Pacira PCRX:US USD 180.36M 1.49M
Phibro Animal Health PAHC:US USD 227.12M 1.68M
Richter Gedeon RICHT:HB HUF 155.46B 68.8B
Sun Pharmaceuticals SUNP:IN INR 89.44B 502.6M
Supernus Pharmaceuticals SUPN:US USD 148.59M 15.59M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 3.66B 1.08B